BIOLIGANDS ApS: Financial statements 2025
CVR: 26603110
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
BIOLIGANDS ApS (CVR 26603110) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -8,258 and a net result of DKK -7,129 compared with DKK -4,850 the year before. Equity in the 2025 report amounted to DKK 62,700. The solvency ratio was 90.7%.
- Gross Profit
- DKK -8,258
- Profit/Loss
- DKK -7,129
- Equity
- DKK 62,700
- Total Assets
- DKK 69,123
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -8 t. | -7 t. | 63 t. | 0 |
| 2024 | - | -6 t. | -5 t. | 70 t. | 0 |
| 2023 | - | -4 t. | -4 t. | 75 t. | - |
| 2022 | - | -5 t. | -5 t. | 79 t. | - |
| 2021 | - | -4 t. | -4 t. | 84 t. | - |
Official annual report
How creditworthy is BIOLIGANDS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BIOLIGANDS ApS
BIOLIGANDS ApS is a Danish company of the type Anpartsselskab based in Odense SV, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named BIOLIGANDS ApS UNDER STIFTELSE. The management consists of Esben Nørgaard Flindt. The board consists of Rasmus Koefoed Petersen. The company's owners include Esben Nørgaard Flindt, Karsten Kristiansen and Hongbin Zhang. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK -8,258 and a net result of DKK -7,129 compared with DKK -4,850 the year before. Equity in the 2025 report amounted to DKK 62,700.